Guided Therapeutics (GTHP) Assets Average (2012 - 2026)
Guided Therapeutics (GTHP) posted Assets Average of $1.1 million for Q4 2025, up 20.84% sequentially from $921500.0 in Q3 2025, and down 15.23% YoY from $1.3 million in Q4 2024.
Guided Therapeutics (GTHP) Assets Average (2012 - 2026) Analysis & Trends
Guided Therapeutics has reported Assets Average for 14 years, with the latest figure at $1.1 million in Q4 2025.
- Quarterly Assets Average fell 15.23% year-over-year to $1.1 million in Q4 2025, while the trailing twelve-month figure through Dec 2025 was $1.1 million (down 15.23% YoY) and the FY2025 annual result came in at $1.4 million, down 11.32% from the prior year.
- Assets Average rose to $1.1 million in Q4 2025 per GTHP's latest filing, from $921500.0 in the prior quarter.
- Over five years, Assets Average peaked at $3.6 million in Q4 2022 and troughed at $921500.0 in Q3 2025.
- A 5-year average of $1.9 million and a median of $1.9 million in 2021 frame the typical range for Assets Average.
- The sharpest annual moves came in 2021 and 2023: Assets Average jumped 239.13% in 2021, then plunged 51.0% in 2023.
- Over 5 years, Assets Average stood at $1.9 million in 2021, then surged by 91.25% to $3.6 million in 2022, then slumped by 51.0% to $1.8 million in 2023, then slipped by 25.92% to $1.3 million in 2024, then fell by 15.23% to $1.1 million in 2025.
- According to Business Quant data, Assets Average over the past three periods registered $1.1 million, $921500.0, and $953500.0 for Q4 2025, Q3 2025, and Q2 2025 respectively.
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Assets Avg. (Qtr) |
|---|---|---|---|---|---|
| 1 | Abbott Laboratories | 198.70 Bn | 193.10 Bn | 7.27 Bn | 109.82 Bn |
| 2 | Stryker | 125.85 Bn | 122.37 Bn | 4.50 Bn | 47.11 Bn |
| 3 | Medtronic | 118.44 Bn | 109.22 Bn | 6.41 Bn | 92.26 Bn |
| 4 | Boston Scientific | 72.64 Bn | 72.10 Bn | 3.85 Bn | 44.78 Bn |
| 5 | Edwards Lifesciences | 51.94 Bn | 47.69 Bn | 1.35 Bn | 13.59 Bn |
| 6 | Dexcom | 34.48 Bn | 32.53 Bn | 830.00 Mn | 6.54 Bn |
| 7 | GE HealthCare Technologies | 33.60 Bn | 31.49 Bn | 2.18 Bn | 37.19 Bn |
| 8 | Koninklijke Philips | 26.30 Bn | 22.98 Bn | 4.55 Bn | 31.48 Bn |
| 9 | Steris | 23.00 Bn | 22.52 Bn | 684.20 Mn | 10.74 Bn |
| 10 | Guided Therapeutics | 26.06 Mn | 26.05 Mn | - | 1.40 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Jun 30, 2026 | 1.26 Mn |
| Dec 31, 2025 | 1.11 Mn |
| Sep 30, 2025 | 921,500.00 |
| Jun 30, 2025 | 953,500.00 |
| Mar 31, 2025 | 1.17 Mn |
| Dec 31, 2024 | 1.31 Mn |
| Sep 30, 2024 | 1.25 Mn |
| Jun 30, 2024 | 1.37 Mn |
| Mar 31, 2024 | 1.58 Mn |
| Dec 31, 2023 | 1.77 Mn |
| Sep 30, 2023 | 2.11 Mn |
| Jun 30, 2023 | 2.62 Mn |
| Mar 31, 2023 | 3.13 Mn |
| Dec 31, 2022 | 3.62 Mn |
| Sep 30, 2022 | 2.69 Mn |
| Jun 30, 2022 | 1.85 Mn |
| Mar 31, 2022 | 2.11 Mn |
| Dec 31, 2021 | 1.89 Mn |
| Sep 30, 2021 | 1.91 Mn |
| Jun 30, 2021 | 2.21 Mn |